Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain

BACKGROUND: Aminoglycosides such as amikacin and kanamycin are effective injectable second-line drugs for treatment of multidrug-resistant tuberculosis. Molecular mechanisms underlying aminoglycoside resistance are not well understood. We have previously identified the amikacin- and kanamycin-resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Sowajassatakul, Angkanang, Prammananan, Therdsak, Chaiprasert, Angkana, Phunpruch, Saranya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047124/
https://www.ncbi.nlm.nih.gov/pubmed/30008266
http://dx.doi.org/10.1186/s12941-018-0285-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047124/
https://www.ncbi.nlm.nih.gov/pubmed/30008266
http://dx.doi.org/10.1186/s12941-018-0285-6

Ejemplares similares